Evidence map›Paper›PMID 37762501›Full record

ReviewInternational journal of molecular sciences2023

Impact of Impaired Kidney Function on Arrhythmia-Promoting Cardiac Ion Channel Regulation.

Frederick Sinha, Frank Schweda, Lars S Maier, Stefan Wagner

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Impact of renal function on the efficacy of low-voltage area ablation after pulmonary vein isolation: a sub-analysis of the SUPPRESS-AF trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Trial
  2. Review
  3. C-H Nitrooxylation: A Shortcut to Nitrate Esters.Topics in current chemistry (Cham) · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Frederick SinhaDepartment for Internal Medicine II, University Medical Center Regensburg, 93053 Regensburg, Germany.ORCID 0000-0003-4260-6767
Frank SchwedaInstitute of Physiology, University of Regensburg, 93053 Regensburg, Germany.
Lars S MaierDepartment for Internal Medicine II, University Medical Center Regensburg, 93053 Regensburg, Germany.ORCID 0000-0001-9915-4429
Stefan WagnerDepartment for Internal Medicine II, University Medical Center Regensburg, 93053 Regensburg, Germany.ORCID 0000-0002-9471-1166
University of Regensburg · DE

Funding

Deutsche Forschungsgemeinschaft TRR 374 TPA6
6 · The paper itself

Abstract

Chronic kidney disease (CKD) is associated with a significantly increased risk of cardiovascular events and sudden cardiac death. Although arrhythmias are one of the most common causes of sudden cardiac death in CKD patients, the molecular mechanisms involved in the development of arrhythmias are still poorly understood. In this narrative review, therefore, we summarize the current knowledge on the regulation of cardiac ion channels that contribute to arrhythmia in CKD. We do this by first explaining the excitation-contraction coupling, outlining current translational research approaches, then explaining the main characteristics in CKD patients, such as abnormalities in electrolytes and pH, activation of the autonomic nervous system, and the renin-angiotensin-aldosterone system, as well as current evidence for proarrhythmic properties of uremic toxins. Finally, we discuss the substance class of sodium-glucose co-transporter 2 inhibitors (SGLT2i) on their potential to modify cardiac channel regulation in CKD and, therefore, as a treatment option for arrhythmias.

Indexed as

Renal InsufficiencyRenal Insufficiency, ChronicSodium-Glucose Transporter 2 InhibitorsArrhythmias, CardiacDeath, Sudden, CardiacHumansIon ChannelsKidneyIon ChannelsSodium-Glucose Transporter 2 Inhibitorsacidosisarrhythmiaautonomic nervous systemCaMKIIcardiac electrophysiologycardio renalchronic kidney diseaseconnexin 43renin–angiotensin–aldosteroneSGLT2 inhibitor

Identifiers

PMID37762501
PMCPMC10532292
OpenAlexW4386814660

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.